Slide 1: First Quarter 2017 Results
First Quarter 2017 Results 5 May 2017 Stephan Holzinger, CEO Dr. Kai G. Klinger RHÖN-KLINIKUM AG - First Quarter 2017 Results - as of May 5, 2017 1
Slide 2: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose
Slide 3: Highlights of First Quarter 2017
Highlights of First Quarter 2017 Moderate growth in volumes at start of FY 2017… +3.2% increase in inpatient and outpatient cases to 212,187 including approx. +1.7%* more DRG case mix points … and an effective kick-off for a corporate change process Realignment of management structures In-
Slide 4: P&L Key Figures
P&L Key Figures Performance* vs. Q1 2017 Restrained sales growth in € millions Q1 2016 Increasing case severity as main driver Revenue 300.1 100.0% +3.0% Rising burdens from regulatory headwinds Personnel exp. -197.2 65.7% +5.0% EBITDA development impacted by extraordinary items Cost of material
Slide 5: Core Balance Sheet Figures End of March 2017
Core Balance Sheet Figures End of March 2017 € 1,471m € 1,471m 63 % € 924m Non-current assets € 1,122m 76 % Equity € 30m cash € 547m 37 % Current assets € 26m Non-current liabilities 2% € 10m Financial debt € 323m Current liabilities 22 % € 268m cash Assets Equity & Liabilities Net cash position €
Slide 6: AGM 2017 Dividend Proposal
AGM 2017 Dividend Proposal The management board and supervisory board will propose to the Annual General Meeting on 7 June 2017 the distribution of a dividend of € 0.35 per share (total dividend sum of €23.4m based on 66.96m shares) “This corresponds to a dividend payout ratio of approx. 40 %. With
Slide 7: Q1 2017 Outlook with General Assumptions
Q1 2017 Outlook with General Assumptions Expected average Expected input price Negative extraordinary Separate accounting at organic growth inflation items (14-16m) UKGM & KEY DRIVERS ASSUMPTIONS +3.0% to +4.0% p.a. Wages +2.0 % to Group realignment and Potential settlement in Average DRG pr
Slide 8: Appendix Financial Calendar
Appendix Financial Calendar FY 2017 24 February 2017 Preliminary results for financial year 2016 7 April 2017 Press conference: publication of annual financial report 2016 5 May 2017 Publication of interim report for the quarter ending 31 March 2017 7 June 2017 Annual General Meeting (Jahrhu
Slide 9: Appendix Price Regulation in 2017 at a Glance
Appendix Price Regulation in 2017 at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level Wage sum increase as main reference number for 1 RHÖN effective base rate Benchmark (wage sum) DRG inflation in 2017: +2.5%
Slide 10: Appendix Shareholder Base
Appendix Shareholder Base Shareholder Structure as of 7 April 2017, according to the most recent notifications of voting rights at that time 25% B. Braun 34.7% 1) 37.9% Free Float 62.1% Strategic Investors 20.2% Asklepios 3.2% Landeskrankenhilfe 5.4% Ingeborg Münch 11.5% 2) Eugen Münch/HCM SE 1) Sha